Skip to content

Use of Intraoperative Radiotherapy in Breast Cancer

Utilización de la Radioterapia IntraOperatoria en la Neoplasia de MAma

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07030231
Acronym
RIOMA
Enrollment
3000
Registered
2025-06-22
Start date
2020-04-01
Completion date
2031-04-01
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Keywords

Breast Cancer, Intraoperative radiotherapy

Brief summary

The Utility of Intraoperative Radiotherapy in Breast Cancer (RIOMA) is an observational project to understand the use and outcomes of intraoperative radiotherapy in patients with breast cancer under conditions of clinical use (not clinical trials). Intraoperative radiotherapy (IORT) is a technique that began to be used years ago, transferring the patient from the operating room to the radiotherapy suite. This technique therefore fell into disuse. The emergence of miniaturized linear accelerators has led to a resurgence of IORT, especially as part of conservative treatment in patients with breast cancer, both as a booster or as a sole treatment (partial breast irradiation). This project is based on an online platform. Each participating center will be assigned access codes on the website to access and complete the coded clinical data for each patient treated with intraoperative radiotherapy. Data on tumor characteristics, the type of intraoperative radiotherapy, follow-up, complications, and cosmetic outcomes are included. Primary objective: To understand the characteristics of patients treated with intraoperative radiotherapy under routine clinical practice conditions.

Detailed description

The project is based on structured data collection in an electronic data collection notebook (using the OpenclinicaTM standard), relating to the care provided according to standard clinical practice in the Radiation Oncology, Gynecology and Surgery departments of the participating centers in Spain.

Interventions

Intraoperative radiotherapy with any device after conservative surgery in early breast cancer

Sponsors

Parc de Salut Mar
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with breast cancer who are candidates for intraoperative irradiation exclusively * Patients with breast cancer who are candidates for intraoperative irradiation combined with external beam irradiation * Patients with recurrence of breast cancer who are candidates for intraoperative irradiation * Have read the information sheet and signed the informed consent form -

Exclusion criteria

* Patient's that express wish not to participate.

Design outcomes

Primary

MeasureTime frameDescription
Characteristics of patients treated with intraoperative radiotherapy according to the conditions of standard clinical practice,From enrollement to the end of recruitment at 10 yearsTo evaluate the characteristics of patients treated with intraoperative radiotherapy according to the conditions of standard clinical practice, retrospectively from the beginning of the implementation of the technique and prospectively from the launch of this registry.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026